No Access
Clozapine treatment of psychosis in Parkinson's disease
Published Online:1 Apr 2006https://doi.org/10.1176/jnp.1.2.190
Abstract
Treating psychosis in patients with Parkinson's disease (PD) is one of the more difficult problems in clinical psychiatry. In this case report, a patient with PD and psychosis was treated with the novel neuroleptic clozapine and sustained improvement in both behavior and PD symptoms.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
